Aiviva BioPharma Inc. Report issue

For profit Phase 1 Phase 2
Founded: Newport Beach CA United States (2015)
Status: No NME R&D (2015)

Organization Overview

First Clinical Trial
2018
NCT03639883
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Alternative names

Aiviva BioPharma Inc. | AiViva BioPharma, Inc.

Active Ingredients

Drugs in Phase 2 Trials (1)

aiv001 (4 trials)

Drugs in Phase 1 Trials (1)

aiv007 (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Carcinoma (Phase 2)

Carcinoma, Basal Cell (Phase 2)

Macular Degeneration (Phase 1)

Rosacea (Phase 2)

Wet Macular Degeneration (Phase 1)

Wounds and Injuries (Phase 2)

Overview

  • Highest Phase: Phase 2
  • # of Trials: 5
  • # of Trial APIs: 2